United States - Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis
Since 2014, United States Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis decreased by 0.5points year on year. With 76 Percent in 2019, the country was ranked number 108 comparing other countries in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis. Norway ranked the highest with 108 Percent in 2019, an increase of 2.9points compared to 2018. Austria, Burundi and Marshall Islands respectively ranked number 2, 3 and 4 in this ranking. Equatorial Guinea recorded the best 5 years average growth at +34.3points per year, while United Arab Emirates recorded the worst performance at -100points per year.
Loading...
| Date | Percent |
|---|---|
| 2019 | 76.00 |
| 2018 | 75.00 |
| 2017 | 77.00 |
| 2016 | 69.00 |
| 2015 | 69.00 |
Download all data from 2004 to 2019
How does United States rank in Treatment Success Rate for Patients Treated for Multidrug-Resistant Tuberculosis?
| # | 313 Countries | Percent | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Norway
|
108.00 % | 2019 | +2.9 % | +3.7 % | View data | |
| 2 |
#2
Austria
|
107.00 % | 2019 | +4.9 % | +11.2 % | View data | |
| 108 |
#108
Timor-Leste
|
76.00 % | 2019 | +4.1 % | -5.3 % | View data | |
| 108 |
#108
United States
|
76.00 % | 2019 | +1.3 % | -0.5 % | View data | |
| 115 |
#115
Turkmenistan
|
75.00 % | 2019 | +7.1 % | +2.3 % | View data | |